Journal of Substance Abuse Treatment
Volume 32, Issue 3 , Pages 301-310 , April 2007

HIV testing in correctional agencies and community treatment programs: The impact of internal organizational structure

  • Carrie B. Oser, Ph.D.

      Affiliations

    • Center on Drug and Alcohol Research, Department of Sociology, University of Kentucky, Lexington, KY 40506, USA
    • Corresponding Author InformationCorresponding author. Center on Drug and Alcohol Research, Department of Sociology, University of Kentucky, 1531 Patterson Office Tower, Lexington, KY 40506, USA. Tel.: +1 859 257 6890; fax: +1 859 323 0272.
    • ,
  • Michele Staton Tindall, Ph.D.

      Affiliations

    • Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky, Lexington, KY 40506, USA
    • ,
  • Carl G. Leukefeld, D.S.W.

      Affiliations

    • Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky, Lexington, KY 40506, USA

Received 27 September 2006 ,Revised 18 December 2006 ,Accepted 25 December 2006.

References 

  1. Adler PS, Borys B. Two types of bureaucracy: Enabling and coercive. Administrative Science Quarterly. 1996;41:61–89
  2. Aiken M, Bacharach SB, French JL. Organizational structure, work process, and proposal making in administrative bureaucracies. Academy of Management Journal. 1980;23:631–652
  3. Bailyn L. Autonomy in the industrial R & D lab. Human Resource Management. 1985;24:129–146
  4. Belenko S, Langley S, Crimmins S, Chaple M. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: A hidden risk group. AIDS Education and Prevention. 2004;16:367–385
  5. Boutwell A, Rich JD. HIV infection behind bars. Clinical Infectious Diseases. 2004;38:1761–1763
  6. Braithwaite RL, Hammett T, Arriola KJ. Introduction to the special issue: HIV/AIDS in correctional settings. AIDS Education and Prevention. 2002;14:1–6
  7. Braithwaite RL, Hammett T, Mayberry R. Prisons and AIDS: A public health challenge. San Francisco, CA: Jossey-Bass; 1996;
  8. Brown LS, Chu A, Nemoto T, Ajuluchukwu D, Primm BJ. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City: Demographic, behavioral, and clinical features. New York State Journal of Medicine. 1989;89:506–510
  9. Brown LS, Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment. 2006;30:315–321
  10. Castle NG, Banaszak-Holl J. Top management team characteristics and innovation in nursing homes. Gerontologist. 1997;37:572–580
  11. Centers for Disease Control and Prevention (CDC) . HIV CT client record reports, 2000, US Total. Retrieved June 1, 2006, from http://www.cdc.gov/hiv/pubs/rt-counseling.htm2000;
  12. Centers for Disease Control and Prevention (CDC) . Twenty-five years of HIV/AIDS — United States, 1981–2006. Morbidity and Mortality Weekly Report. 2006;48:52–55
  13. Cohn SF, Turyn RM. The structure of the firm and the adoption of process innovations. IEEE Transactions on Engineering Management. 1980;27:98–102
  14. Damanpour F. Organizational innovation: A meta-analysis of effects of determinants and moderators. Academy of Management Journal. 1991;34:555–590
  15. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatients drug abuse treatment units. Journal of Health and Social Behavior. 1999;40:175–192
  16. Dean HD, Lanksky A, Fleming PL. HIV surveillance methods for the incarcerated population. AIDS Education and Prevention. 2002;14:65–74
  17. Diamond MA. Organizational change as human process, not technique. In:  Backer TE,  David SL,  Soucy G editor. Reviewing the behavioral science knowledge base on technology transfer: NIDA research monograph No. 155. Rockville, MD: National Institute on Drug Abuse (NIDA); 1995;p. 119–131
  18. Drazin R, Schoonhowern C. Community, population, and organization effects on innovation: A multilevel perspective. Academy of Management Journal. 1996;39:1065–1083
  19. Estelle v. Gamble. (1976) 429 US 97. U.S. Supreme Court.
  20. Fennell ML. Synergy, influence, and information in the adoption of administrative innovations. Academy of Management Journal. 1984;27:113–129
  21. Fichman FG. The role of aggregation in the measurement of IT-related organizational innovation. MIS Quarterly. 2001;25:427–455
  22. Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Journal of Substance Abuse Treatment. 1999;16:71–80
  23. Glaser JB, Griefinger RB. Correctional health care: A public health opportunity. Annuals of Internal Medicine. 1993;118:139–145
  24. Glassman AM. Rethinking organization stability as a determinant for innovation adoption and diffusion. In:  Backer TE,  David SL,  Soucy G editor. Reviewing the behavioral science knowledge base on technology transfer: NIDA research monograph No. 155. Rockville, MD: NIDA; 1995;p. 132–146
  25. Glaze LE, Palla S. Probation and parole in the United States, 2004. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 2005;(Publication No. NCJ 210676)
  26. Hammett TM. Public health/corrections collaborations: Prevention and treatment of HIV/AIDS, STDs, and TB. Washington, DC: U.S. Department of Justice, Office of Justice Programs, National Institute of Justice; 1998;(Publication No. NCJ 169590)
  27. Hammett TM, Harmon P. Sexually transmitted diseases and hepatitis: Burden of disease among inmates. In:  Hammett TM,  Harmon P,  Maruschak LM editor. 1996–1997 update: HIV/AIDS, STDs, and TB in correctional facilities. Washington, DC: U.S. Department of Justice, Office of Justice Programs, National Institute of Justice; 1999;p. 132–146(Publication No. NCJ 176344)
  28. Hammett TM, Harmon P, Maruschak LM. 1996–1997 update: HIV/AIDS, STDs and TB in correctional facilities. Washington, DC: U.S. Department of Justice, Office of Justice Programs, National Institute of Justice; 1999;(Publication No. NCJ 176344)
  29. Hammett TM, Harmon P, Rhodes W. The burden of infectious disease among inmates and releases from US correctional facilities, 1997. American Journal of Public Health. 2002;92:189–194
  30. Harrison PM, Beck AJ. Prisoners in 2004. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 2005;(Publication No. NCJ 210677)
  31. Harrison PM, Beck AJ. Prison and jail inmates at midyear 2005. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 2006;(Publication No. NCJ 213133)
  32. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, NYC. Public Health Report. 1998;113:107–115
  33. James DJ. Profile of jail inmates, 2002. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 2004;(Publication No. NCJ 201932)
  34. Kavanagh KH. Collaboration and diversity in technology transfer. In:  Backer TE,  David SL,  Soucy G editor. Reviewing the behavioral science knowledge base on technology transfer: NIDA research monograph No. 155. Rockville, MD: NIDA; 1995;p. 42–64
  35. Kimberly JR, Evanisko MJ. Organizational innovation: The influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Academy of Management Journal. 1981;24:689–713
  36. Knudsen H, Johnson JA, Roman P, Oser C. Rural and urban similarities and differences in private substance abuse treatment centers. Journal of Psychoactive Drugs. 2003;35:511–518
  37. Knudsen H, Roman P. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment. 2004;26:51–59
  38. Lally MA, MacNevin R, Sergie Z, Hitt R, Dispigno M, Cenedella C, et al. A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug abuse treatment center. AIDS Patient Care STDS. 2005;19:298–305
  39. Lehman WEK, Greener JM, Simpson DD. Assessing organizational readiness for change. Journal of Substance Abuse Treatment. 2002;22:197–209
  40. Maruschak LM. HIV in prisons, 2003. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 2005;(Publication No. NCJ 210344)
  41. McGill ME, Slocum JW, Lei D. Management practices in learning organizations. Organizational Dynamics. 1992;21:5–16
  42. McLeory KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Education Quarterly. 1988;15:351–377
  43. Mertler CA, Vannatta RA. Advanced and multivariate statistical methods. Los Angeles, CA: Pyrczak Publishing; 2002;
  44. Meyer M, Johnson JD, Ethington C. Contrasting attributes of preventive health innovations. Journal of Communication. 1997;47:112–131
  45. Miller D, Friesen PH. Innovation in conservative and entrepreneurial firms: Two models of strategic momentum. Strategic Management Journal. 1982;3:1–25
  46. Mosen DM, Wenger NS, Shapiro MF, Andersen RM, Cunningham WE. Is access to medical care associated with receipt of HIV testing and counseling?. AIDS Care. 1998;10:617–628
  47. Mumola C. Substance abuse and treatment, state and federal prisoners, 1997. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics,; 1999;(Publication No. NCJ 172871)
  48. Nicholson-Crotty J, Nicholson-Crotty S. Social construction and policy implementation: Inmate health as a public health issue. Social Science Quarterly. 2004;85:240–256
  49. Oser C, Leukefeld C, Staton Tindall M, Havens J, Webster JM, Smiley-McDonald H, et al. Male and female rural probationers: HIV risk behaviors and knowledge. AIDS Care Journal. 2006;18:339–344
  50. Raelin JA. The dilemma of autonomy vs. control in the management of organizational professionals. Human Resource Management. 1985;24:123–127
  51. Rogers EM. Diffusion of innovations. 5th ed.. New York: The Free Press; 2003;
  52. Roman PM, Johnson JA. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment. 2002;22:1–8
  53. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: A review. Clinical Infectious Diseases. 2002;35:305–312
  54. Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Current HIV/AIDS Reports. 2005;2:165–170
  55. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: Recincarceration and the lack of sustained benefit after release to the community. Clinical Infectious Diseases. 2004;38:1754–1760
  56. Stein JA, Nyamathi A. Gender differences in behavioral and psychosocial predictors of HIV testing and return for results in a high-risk population. AIDS Care. 2000;12:343–356
  57. Taxman FS, Young DW, Wiersema B, Rhodes A, Mitchell S. The national criminal justice treatment practices survey: Multilevel survey methods and procedures. Journal of Substance Abuse Treatment. 2007;32:225–238
  58. Wohl DA, Stephenson BL, Golin CE, Kiziah CN, Rosen D, Ngo B, et al. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases. 2003;36:1572–1576

PII: S0740-5472(07)00012-8

doi: 10.1016/j.jsat.2006.12.016

Journal of Substance Abuse Treatment
Volume 32, Issue 3 , Pages 301-310 , April 2007

Article Tools